Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.61M Buy
26,738
+4,168
+18% +$678K 0.13% 70
2017
Q1
$3.7M Buy
22,570
+10,176
+82% +$1.69M 0.1% 102
2016
Q4
$1.81M Sell
12,394
-66,622
-84% -$10M 0.04% 360
2016
Q3
$13.2M Buy
79,016
+74,592
+1,686% +$12.6M 0.31% 23
2016
Q2
$673K Buy
4,424
+1,484
+50% +$231K 0.01% 1075
2016
Q1
$441K Buy
2,940
+191
+7% +$28.4K 0.01% 1327
2015
Q4
$446K Sell
2,749
-61,471
-96% -$9.66M 0.01% 1683
2015
Q3
$8.88M Buy
64,220
+12,832
+25% +$2.02M 0.15% 70
2015
Q2
$7.89M Buy
51,388
+21,308
+71% +$3.41M 0.14% 69
2015
Q1
$4.81M Sell
30,080
-15,096
-33% -$2.38M 0.1% 127
2014
Q4
$7.2M Buy
45,176
+42,414
+1,536% +$6.61M 0.12% 79
2014
Q3
$388K Sell
2,762
-10,539
-79% -$1.38M 0.01% 1984
2014
Q2
$1.57M Sell
13,301
-1,525
-10% -$177K 0.02% 723
2014
Q1
$1.83M Sell
14,826
-19,098
-56% -$2.32M 0.02% 751
2013
Q4
$3.87M Buy
33,924
+14,568
+75% +$1.66M 0.04% 332
2013
Q3
$2.17M Buy
+19,356
New +$2.1M 0.03% 580

Other funds holding AMGN

Virtu KCG Holdings's AMGN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Amgen (AMGN) stake by 18% in Q2 2017, buying an estimated $678K and bringing the position to 26,738 shares worth $4.61M. The position accounts for 0.13% of the portfolio, ranked #70.

Virtu KCG Holdings first reported a position in AMGN in Q3 2013 and has held it in 16 quarters since. The position peaked at $13.2M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Virtu KCG Holdings held 26,738 shares of Amgen worth $4.61M as of Q2 2017.
  • Virtu KCG Holdings bought 4,168 Amgen shares in Q2 2017, an estimated $678K.
  • Amgen made up 0.13% of Virtu KCG Holdings's portfolio in Q2 2017, its #70 holding.
  • Virtu KCG Holdings first reported a position in Amgen in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Amgen position peaked at $13.2M in Q3 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.